F. Maindrault-Gœbel
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 21
- Colorectal Cancer Treatments and Studies 17
- Cancer Treatment and Pharmacology 14
- HER2/EGFR in Cancer Research 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Co-authors
- Thierry André (16 shared papers)Christophe Louvet (11 shared papers)Jean‐Pierre Lotz (4 shared papers)Aimery de Gramont (9 shared papers)Élisabeth Carola (6 shared papers)May Mabro (8 shared papers)M Krulik (4 shared papers)V. Izraël (3 shared papers)
In The Last Decade
F. Maindrault-Gœbel
21 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 64
- Hepatology 330
- Oncology 1.0k
- Pulmonary and Respiratory Medicine 461
- Surgery 405
- Pathology and Forensic Medicine 131
Countries citing papers authored by F. Maindrault-Gœbel
This map shows the geographic impact of F. Maindrault-Gœbel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Maindrault-Gœbel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Maindrault-Gœbel more than expected).
Fields of papers citing papers by F. Maindrault-Gœbel
This network shows the impact of papers produced by F. Maindrault-Gœbel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Maindrault-Gœbel. The network helps show where F. Maindrault-Gœbel may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Maindrault-Gœbel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 309 | |
| 2 | 1999 | 235 | |
| 3 | 1999 | 222 | |
| 4 | 2001 | 114 | |
| 5 | 2004 | 70 | |
| 6 | 2007 | 69 | |
| 7 | 2006 | 35 | |
| 8 | 2009 | 32 | |
| 9 | 2006 | 23 | |
| 10 | 2007 | 23 | |
| 11 | 2009 | 12 | |
| 12 | 2008 | 11 | |
| 13 | 1999 | 10 | |
| 14 | 2011 | 10 | |
| 15 | 2008 | 5 | |
| 16 | 2006 | 4 | |
| 17 | 2009 | 3 | |
| 18 | 2010 | 3 | |
| 19 | 2004 | 2 | |
| 20 | 2003 | 1 |
About F. Maindrault-Gœbel
F. Maindrault-Gœbel is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Molecular Biology and Surgery, having authored 22 papers that have together received 1.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (17 papers), Cancer Treatment and Pharmacology (14 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Gastric Cancer Management and Outcomes (4 papers), Genetic factors in colorectal cancer (2 papers), Lung Cancer Treatments and Mutations (2 papers), HER2/EGFR in Cancer Research (2 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers). The work is most often cited by research in Hepatology (330 citations), Oncology (1.0k citations), Pulmonary and Respiratory Medicine (461 citations), Surgery (405 citations) and Pathology and Forensic Medicine (131 citations). F. Maindrault-Gœbel has collaborated with scholars based in France, Morocco and Israel. Frequent co-authors include Thierry André, Christophe Louvet, Jean‐Pierre Lotz, Aimery de Gramont, Élisabeth Carola, May Mabro, M Krulik, V. Izraël, Christophe Tournigand and Armand de Gramont. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, British Journal of Cancer and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.